IL-23 promotes tumour incidence and growth
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Chronic inflammation has long been associated with increased incidence of malignancy and similarities in the regulatory mechanisms have been suggested for more than a century. Infiltration of innate immune cells, elevated activities of matrix metalloproteases and increased angiogenesis and vasculature density are a few examples of the similarities between chronic and tumour-associated inflammation. Conversely, the elimination of early malignant lesions by immune surveillance, which relies on the cytotoxic activity of tumour-infiltrating T cells or intra-epithelial lymphocytes, is thought to be rate-limiting for the risk to develop cancer. Here we show a molecular connection between the rise in tumour-associated inflammation and a lack of tumour immune surveillance. Expression of the heterodimeric cytokine interleukin (IL)-23, but not of its close relative IL-12, is increased in human tumours. Expression of these cytokines antagonistically regulates local inflammatory responses in the tumour microenvironment and infiltration of intra-epithelial lymphocytes. Whereas IL-12 promotes infiltration of cytotoxic T cells, IL-23 promotes inflammatory responses such as upregulation of the matrix metalloprotease MMP9, and increases angiogenesis but reduces CD8 T-cell infiltration. Genetic deletion or antibody-mediated elimination of IL-23 leads to increased infiltration of cytotoxic T cells into the transformed tissue, rendering a protective effect against chemically induced carcinogenesis. Finally, transplanted tumours are growth-restricted in hosts depleted for IL-23 or in IL-23-receptor-deficient mice. Although many strategies for immune therapy of cancer attempt to stimulate an immune response against solid tumours, infiltration of effector cells into the tumour tissue often appears to be a critical hurdle. We show that IL-23 is an important molecular link between tumour-promoting pro-inflammatory processes and the failure of the adaptive immune surveillance to infiltrate tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 also induces proliferative signaling in keratinocytes through Act1, a major facet of its impact in psoriasis and perhaps also explaining its involvement in skin tumorigenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
In the citing paper
“this pro-proliferative role likely contributes to the pathogenic effects of IL-17 in psoriasis, as well as potentially in skin cancer”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
In the citing paper
“In addition, as discussed above, IL-17 promotes proliferation of skin epithelial cells to promote tumorigenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Cited by
Items 901–1,000 of 1,000
Rewiring of signaling pathways by HCMV-encoded GPCRs
Slinger, E. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
MOLECULAR MECHANISMS UNDERLYING THE TRANSCRIPTIONAL REGULATION OF T HELPER 17 AND REGULATORY T CELLS
Martínez, G. (2011) · Digital Commons-TMC (Texas Medical Center)
Targeting Th (Th17 and Th2) suppressive and stimulatory effect on cytotoxic T cells
Munegowda, M. A. (2012)
Role of Notch Signaling in T Cell Polarization
Keerthivasan, S. (2011) · Loyola eCommons (Loyola University of Chicago)
TH17 Cells in Cancer Related Inflammation
Rupinder, K., & Jagat, R. (2012) · InTech eBooks · doi:10.5772/39046
“Another cytokine, IL-23 required for TH17 activity has been identified as a cancer-associated cytokine because it promotes tumour incidence and growth (Langowski et al., 2006).”
BackgroundInnate Immunity, Inflammation and Colorectal Cancer
Wang, K., Grivennikov, S. I., & Karin, M. (2013) · Else Kröner-Fresenius Symposia · doi:10.1159/000346526 · Cited by 1
Chaves, A. A. M. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2013.tde-27012014-174647 · Cited by 1
Immunotoxicology of Biopharmaceutics
Haggerty, H. G., Price, K., & Shenton, J. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00629-1
Role of IL12 Family in Regulation of Antitumor Immune Response
Dibra, D., & Li, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0170-5_1
Workshop AIEOP... in Lab, Milano, 22-23 October 2009
Caliendo, I., Concilio, R. D., Danise, P., Guerriero, A., Aurino, A. M., Amendolara, M., D’Urzo, G., Luciano, L., Ingenito, M., & Amendola, G. (2009) · Pediatric Reports · doi:10.4081/pr.2009.s1
The Pro-inflammatory Milieu and Its Role in Malignant Epithelial Initiation
Yagui‐Beltrán, A., Tang, Q., & Jablons, D. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_20
An immunological perspective on skin disease
Foley, P. A. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.09.011 · Cited by 1
Sharma, A., & Czerniecki, B. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.31
Cell-Nonautonomous ER Stress-Mediated Dysregulation of Immunity by Cancer Cells
Rodvold, J. J., Mahadevan, N. R., & Zanetti, M. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_18
Carrascosa, J. M. (2012) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(12)70003-0
Towards effective TCR gene therapy: preclinical requirements
Pouw, N. M. C. (2010) · RePub (Erasmus University Rotterdam)
THE ROLE OF HEAT SHOCK PROTEIN RECEPTOR CD91 IN INITIATION OF TUMOR-ASSOCIATED IMMUNITY
Zhou, Y. J. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Xie, S. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
Appenteng, K. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
IL-23 and IL-17: function, disease and therapy
Conte, D. (2007)
Aspectos Moleculares do Cancro do Colo do Útero - Variantes genéticas como factores de risco
Catarina, I., & Dutra, F. (2010)
A study on crosstalk between lung carcinoma and immune cells
Mushtaq, Q. D. (2012) · Shodhganga
Role of Cathepsin C During Breast Cancer Metastasis
Ruffell, B. (2011) · Defense Technical Information Center (DTIC) · doi:10.21236/ada554585
Westin, A. T. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-03092014-230644
STAT signaling as a molecular target for cancer therapy
Yu, H., & Jove, R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.026 · Cited by 1
Immunstimulatorische RNA-Oligonukleotide aktivieren T- und NK-Zellen über Toll-like-Rezeptor 7
München, L.-M.-U. (2010)
Running Title: Tim-3 function in human NK cells
Gleason, M., Lenvik, T. R., McCullar, V., Felices, M., Cooley, S., Verneris, M. R., Cichocki, F. M., Holman, C., Niki, T., Hirashima, M., et al. (2016)
Adaptive Immunity including Organization of Lymphoid Tissues
Dustin, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10017-8
Zhao, E., Wang, L., Wei, S., Kryczek, I., & Zou, W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00010-5
STAT3 and Src Signaling in Melanoma
Kujawski, M., Cherryholmes, G. A., Priceman, S. J., & Yu, H. (2011) · Springer eBooks · doi:10.1007/978-1-61779-407-0_7
Acker, A. V. (2016) · Ghent University Academic Bibliography (Ghent University)
Revealing the role of receptor WSX1: a double-edged sword in tumor progession
Dibra, D. (2010) · Louisiana State University · doi:10.31390/gradschool_dissertations.4050
Caractérisation et influence des lymphocytes T CD4 anti-télomérase dans les cancers
Dosset, M. (2012) · theses.fr (ABES) · doi:10.70675/f11f022bzcc58z45a9z95d7zbc676c861177 · Cited by 1
Computational framework for systematic and scalable analysis of deep sequencing transcriptomics data
Taboada, A. C. (2012) · Työväentutkimus Vuosikirja
Zöller, J. (2016) · mediaTUM (Technical University of Munich)
Ustekinumab and Marked Clinical Responses in Patients with Moderate to Severe Psoriasis
Reich, K., Shakery, K., Mrowietz, U., Szapary, P. O., Wang, Y., Hsu, M.-C., & Langley, R. G. B. (2010) · Psoriasis Forum · doi:10.1177/247553031016a00101
Bryant, D., & Ayoub, N. (2009) · Psoriasis Forum · doi:10.1177/247553030915a00210
Novel Therapeutic Approaches for Inflammatory Bowel disease
Fiteih, Y. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r34h4s
Rôle de TLR7 dans la progression tumorale dans le cancer du poumon
Dajon, M. (2017) · theses.fr (ABES) · doi:10.70675/77bf9d7bz4487z408dzbe06z1b66cc3fb5b6
Tumor Antigens and Immune Regulation in Cancer Immunotherapy
Wang, R., & Wang, H. Y. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9914-6_21
THE ROLE OF THE TUMOR MICROENVIRONMENT IN WALDENSTRÖM MACROGLOBULINEMIA
Han, W. (2019) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Pancreatic Adenocarcinoma Growth Retardation in a Psoriasis Patient on Ustekinumab
Sheriff, T., Thomas, D. B., & Murrell, D. F. (2020) · Journal of Skin and Stem Cell · doi:10.5812/jssc.104489
“Tumors such as pancreatic and colorectal cancer are reported to be rich in myeloid cells such as myleoid derived suppressor cells (MDSC) and/or tumor-associated macrophages (TAM) (3).”
BackgroundUtilización de agonistas de receptores tipo toll 3 en escenarios terapéuticos antitumorales
Nocera, D. A. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
LeQuang, J. A. (2020) · The journal of clinical and aesthetic dermatology
Translating Breast Cancer Immune Features into Biomarkers and Therapies
Saraiva, D. I. P. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Mouse Mast Cell Protease 4 Protects Against Ultraviolet-B Induced Skin Tumourigenesis
Taing, H. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Utilisation de l'absorption saturable pour la réalisation d'un reservoir computer tout optique
Duport, F., Dejonckheere, A., Smerieri, A., Li, F., Oudar, J., Haelterman, M., & Massar, S. (2013) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Targeting Inflammatory Pathways in Epithelial Ovarian Cancer
Coward, J. I. G., & Balkwill, F. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7216-3_7
Kolls, J. K., & McAleer, J. P. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718003677.793475711
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_2
Meager, A., & Wadhwa, M. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0000932.pub3 · Cited by 1
Immunotoxicology of Biopharmaceutics☆
Haggerty, H. G., Price, K., & Shenton, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02008-0
Yeo, N. J. Y. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155373
Жукова, О. В., & Artemyeva, S. I. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-3-71-78
Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling
Radosavljevic, G. D., Pantic, J. M., Marković, B. S., & Arsenijević, N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102893 · Cited by 2
Using Natural Adjuvants to Stimulate Anti-Tumour Immune Responses
Kuhn, S. P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17011490
Emer, J. J., Larian, A. A., & Lebwohl, M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2003-7.00026-1
Strategies of the War on Cancer: To Kill or to Neutralize?
Lichtenstein, A. V. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr.1.2020.1
Han, G., Ryan, C., & Leonardi, C. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-54859-9_15
Joshipura, D., Rothstein, B. E., & Rosmarin, D. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-54859-9_16
Moser, M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1168396.630574
Interleukin-12 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00007-5
Mamoor, S. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/k74fj
Meager, A., & Wadhwa, M. (2007) · Wiley eBooks · doi:10.1002/9780470015902.a0000932.pub2
Glance on the Critical Role of IL-23 Receptor Gene Variations in Inflammation-Induced Carcinogenesis
El‐Gedamy, M. S. (2023) · Biochemistry · doi:10.5772/intechopen.105049 · Cited by 1
Gad, S. A., Elnagar, A., Hussien, S., Abdelrahman, A., Elfarargy, O. M., & Alagrody, A. (2022) · african journal of gastroenterology and hepatology · doi:10.21608/ajgh.2022.151904.1009
“Therefore, there was an urgent need to study the association between genetic variations and the occurrence of HCC [18].”
BackgroundWise-Draper, T. M., Mintz-Cole, R. A., Morris, T. A., Simpson, D. S., Wikenheiser‐Brokamp, K. A., Currier, M. A., Cripe, T. P., Grosveld, G. C., & Wells, S. I. (2023) · doi:10.1158/0008-5472.c.6499784.v1
Nam, J., Terabe, M., Kang, M., Chae, H., Voong, N., Yang, Y.-A., Laurence, A. D. J., Michalowska, A. M., Mamura, M., Lonning, S. M., et al. (2023) · doi:10.1158/0008-5472.c.6497676.v1
Study of serum for some immune factors indicators of interleukin-23 in thyroiditis disease patients
Fadhil, Z. A., Hassan, I. B., & Qaym, A. N. A. (2023) · AIP conference proceedings · doi:10.1063/5.0105665
Sheldon, H., Bridges, E., Silva, I., Masiero, M., Favara, D. M., Wang, D., Leek, R., Snell, C. E., Roxanis, I., Kreuzer, M., et al. (2023) · doi:10.1158/1541-7786.c.6545234
Data from NF-κB Fans the Flames of Lung Carcinogenesis
Wong, K., Jacks, T., & Dranoff, G. (2023) · doi:10.1158/1940-6207.c.6544686.v1
Tejera, C. M. (2023) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/59773
Singh, H., Patel, V., SHARMA, D., SHARMA, N., Razdan, R. A., & Parihar, N. (2022) · University Journal of Dental Sciences · doi:10.21276//ujds.2023.9.1.17 · Cited by 1
Chae, Y. J., Lee, K.-G., Oh, D., Lee, S., Park, Y., & Kim, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563185
Kim, J., Park, Y., Chae, Y. J., Lee, K.-G., Oh, D., & Lee, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3468161/v1
The Role of Cytokines in the Pathogenesis of Malignant Neoplasms
Львовна, Р. В., Adamova, G. V., & Oslina, D. S. (2023) · Cell and Tissue Biology · doi:10.1134/s1990519x23060111
“The presence of IL-23p19 deficiency in mice or treatment with anti-IL-23p19 antibodies has been shown to increase CD8 T cell infiltration into skin treated with DMBA/TPAIL (Langowski et al., 2006).”
BackgroundKhan, I. A., Singh, N., Gunjan, D., Dash, N. R., Nayak, B., Gupta, S., & Saraya, A. (2024) · Human Immunology · doi:10.1016/j.humimm.2023.110748
Dai, J., Huang, H., Zhang, H., Yang, B., & Tang, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4143609/v1
Melanoma Risk with Immunomodulators
Ortiz‐Urda, S., Ho, W. W.-S., & Lee, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59128-0_14
Innate Lymphoid Cells in Cancer: Immunobiology and Immunotherapy
Sousa, L. M., Tralhão, J. G., Ferreira, M. M., & Rodrigues‐Santos, P. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_368
Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5481-4
[Artículo traducido] Risankizumab en el tratamiento de la psoriasis en pacientes trasplantados
Luz, M., Lé, A. M., & Torres, T. R. (2024) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2024.10.032
HSPA4 Expression is Correlated with Melanoma Cell Proliferation, Prognosis, and Immune Regulation
Wang, X., Li, Z., Xu, J., Wang, J., Li, Y., Li, R. Q., Niu, J., & Yang, R. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s477870
Aires, I., Parada, B., Ferreira, R. M., & Oliveira, P. A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2465373 · Cited by 1
The IL-12/IL-23 Cytokine Family
Clavijo-Salomon, M. A., Trinchieri, G., & Pistoia, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00141-1
Immunotoxicology of Biopharmaceutics
Haggerty, H. G., Price, K., & Shenton, J. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.50043-6
Gioacchino, M. D., Pagana, A., Mirabile, G., Valle, L. D., Stagno, F., Gangemi, S., & Allegra, A. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003226
Pepe, F. F., Cazzaniga, M. E., Baroni, S., Riva, F., Cicchiello, F., Capici, S., Cogliati, V., Maggioni, C., Cordani, N., Cerrito, M. G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21018918
Salvador, R. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Μελέτη του ρόλου του IncRNA GrACILe3 στον καρκίνο του στομάχου με CRISPR-activation
Τσικλή, Β. (2019) · University of Thessaly Institutional Repository (University of Thessaly)
Serum levels of IL-12 and IL-23 in dogs with lymphoma and solid tumours
Hedman, I. (2024) · Epsilon Archive for Student Projects (University of Southampton)
Development of in vivo models to study candida infections and innate immune responses
Rogiers, O. (2022) · Lirias
Peña Tomey, L., Barrio, M. V. F. D., & Gracia‐Cazaña, T. (2023) · Zaguan (University of Zaragoza Repository) · Cited by 1
Folding and quality control of the cytokines interleukin 12 and interleukin 23
Meier, S. (2019) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
Metadata
- Authors
- Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M.
- Corresponding author
- Oft, Martin
- Venue
- Nature
- Published
- 2006-05-10
- Volume
- 442
- Issue
- 7101
- Pages
- 461-465
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1984467626
- Cited by
- 1,018
- References
- 30
- Citations by year
- 2026: 23 · 2025: 18 · 2024: 32 · 2023: 46 · 2022: 42 · 2021: 44 · 2020: 41 · 2019: 52 · 2018: 41 · 2017: 41 · 2016: 41 · 2015: 47 · 2014: 62 · 2013: 72 · 2012: 65
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- IL-23, tumour-associated inflammation, tumor surveillance, CD8+ T cell infiltration, intraepithelial lymphocytes, tumor microenvironment, angiogenesis, MMP-9, IL-12, chemical carcinogenesis, IL23R, tumor growth, cancer immunotherapy
- MeSH terms
- Animals, Cell Division, Humans, Inflammation, Interleukins, Mice, Inbred C57BL, Neoplasms, Signal Transduction, CD8-Positive T-Lymphocytes, Interleukin-12, Genetic Predisposition to Disease, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.